Reversal of docetaxel resistance in prostate cancer by Notch signaling inhibition-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reversal of docetaxel resistance in prostate cancer by Notch signaling inhibition

Published:2018-10 Issue:9 Volume:29 Page:871-879
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Qiu Shi,Deng Linghui,Bao Yige,Jin Kun,Tu Xiang,Li Jiakun,Liao Xinyang,Liu Zhenhua,Yang Lu,Wei Qiang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference34 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Functional quality-of-life outcomes reported by men treated for localized prostate cancer: a systematic literature review;Baker;Oncol Nurs Forum,2016

3. Targeted therapeutic approaches for hormone-refractory prostate cancer;Stavridi;Cancer Treat Rev,2010

4. Integrative clinical genomics of advanced prostate cancer;Robinson;Cell,2015

5. Is prostate cancer changing?: evolving patterns of metastatic castration-resistant prostate cancer;Doctor;Cancer,2014

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro modulation the Notch pathway by piperine: A therapeutic strategy for docetaxel‐resistant and non‐resistant prostate cancer;Chemical Biology & Drug Design;2024-06

2. WITHDRAWN: Insights into the Biological Properties of Prostate Cancer Stem Cells: Implications for Cancer Progression and Therapy;Current Stem Cell Research & Therapy;2024-01-23

3. Prostate Cancer Stem Cells: Biology and Treatment Implications;International Journal of Molecular Sciences;2023-10-04

4. Cancer stem cell in prostate cancer progression, metastasis and therapy resistance;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-05

5. Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies;Biomedicine & Pharmacotherapy;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3